Results

Total Results: 1,195 records

Showing results for "therapy".

1. Archived: Postmenopausal Hormone Replacement Therapy for Primary Prevention of Chronic Conditions: Evidence Summary: Menopausal Hormone Therapy: Preventive Medication, 2002 and 2005 | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/postmenopausal-hormone-replacement-therapy-for-primary-preve/v2-menopausal-hormone-therapy-preventive-medicatio
   August 21, 2002 - Use of HRT for the treatment of symptoms of menopause and for the treatment of preexisting conditions … Hormone replacement treatment and breast cancer risk: an age-specific analysis. … Oral contraceptives, menopausal hormone replacement treatment and breast cancer risk. … Fracture protection provided by long-term estrogen treatment. … Treatment adherence and risk of death after a myocardial infarction.

2. Archived: Postmenopausal Hormone Replacement Therapy for Primary Prevention of Chronic Conditions: Evidence Summary: Menopausal Hormone Therapy: Preventive Medication, 2002 and 2005 | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/postmenopausal-hormone-replacement-therapy-for-primary-preve/menopausal-hormone-therapy-preventive-medication-2002-2005
   August 21, 2002 - Use of HRT for the treatment of symptoms of menopause and for the treatment of preexisting conditions … Hormone replacement treatment and breast cancer risk: an age-specific analysis. … Oral contraceptives, menopausal hormone replacement treatment and breast cancer risk. … Fracture protection provided by long-term estrogen treatment. … Treatment adherence and risk of death after a myocardial infarction.

3. Recommendation: Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication
   November 01, 2022 - are limited to the treatment of menopausal symptoms and the prevention of postmenopausal osteoporosis … for the treatment of menopausal symptoms (eg, vasomotor hot flashes or vulvovaginal symptoms) or for … have reported on the risk of breast cancer as one of the primary adverse outcomes of treatment. … The comparative benefits and harms of different formulations and treatment durations of menopausal hormone … or for the prevention of osteoporosis, if alternative therapies are not tolerated, based on a careful

4. Hormone Therapy to Prevent Chronic Conditions in Postmenopausal People (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/NyXe34ymZQ4doqnZdWHxed
   May 16, 2022 - Hormone Therapy to Prevent Chronic Conditions in Postmenopausal People … What is hormone therapy? … There are two types of hormone therapy. … Click Here to Learn More About Hormone Therapy Menopausal Hormone Therapy and Cancer (National Cancer … Institute) Hormone Replacement Therapy (MedlinePlus) Menopausal Hormone Therapy Information

5. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: USPSTF Recommendation Statement (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/VKGPkVjto7K4yfUHBKEHBA
   January 01, 2025 - Treatment and Intervention Menopausal hormone therapy refers to the use of combined estro- gen and progestin … The use of hormone therapy, whether administered orally, transder- mally, or locally for the treatment … have reported on the risk of breast cancer as one of the primary adverse outcomes of treatment. … The Endocrine Society40 also focuses pri- marily on the use of hormone therapy for the treatment of symp … Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline.

6. Draft Recommendation: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/menopausal-hormone-therapy-postmenopausal-persons-primary-prevention-chronic-conditions
   April 19, 2022 - Food and Drug Administration in menopausal persons are limited to the treatment of menopausal symptoms … for the treatment of menopausal symptoms (e.g., vasomotor hot flashes or vulvovaginal symptoms) or for … have reported on the risk of breast cancer as one of the primary adverse outcomes of treatment. … The comparative benefits and harms of different formulations and treatment durations of menopausal hormone … or for the prevention of osteoporosis, if alternative therapies are not tolerated, based on a careful

7. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: US Preventive Services Task Force Recommendation Statement (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/v7w4xaGG822hVc_SCU3tQ_
   November 01, 2022 - are limited to the treatment of menopausal symptoms and the prevention of post- menopausal osteoporosis … for the treatment of menopausal symptoms (eg, vasomotor hot flashes or vulvovaginal symptoms) or for … have reported on the risk of breast cancer as one of the primary adverse outcomes of treatment. … significantly higher risk of gallbladder disease in persons random- ized to estrogen plus progestin treatment … • The comparative benefits and harms of different formulations and treatment durations of menopausal

8. Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/XAJcRkY9ACZwenBYjopCrB
   October 01, 2012 - What is menopausal hormone therapy? … Combined Hormone Therapy with Estrogen and Progestin For every 10,000 women who use combined therapy … Grade D 2 Should You Use Hormone Therapy to Prevent Chronic Conditions? … The Task Force recommendations do not cover diagnosis (tests to find out why you are sick) or treatment … Click Here to Learn More About Menopause and Hormone Therapy Postmenopausal Hormone Therapy: Information

9. Archived: Menopausal Hormone Therapy: Preventive Medication, 2002 and 2005 | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/recommendation/v2-menopausal-hormone-therapy-preventive-medicatio
   May 09, 2005 - hormone therapy for prevention of chronic disease (e.g., age differences). … Postmenopausal Hormone Replacement Therapy and Cardiovascular Disease . … Hormone Replacement Therapy and Risk of Venous Thromboembolism . … Hormone Replacement Therapy and Cognition . … ACOG Task Force on Hormone Therapy. Hormone Therapy.

10. Archived: Menopausal Hormone Therapy: Preventive Medication, 2002 and 2005 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication-2002-2005
    May 09, 2005 - hormone therapy for prevention of chronic disease (e.g., age differences). … Postmenopausal Hormone Replacement Therapy and Cardiovascular Disease . … Hormone Replacement Therapy and Risk of Venous Thromboembolism . … Hormone Replacement Therapy and Cognition . … ACOG Task Force on Hormone Therapy. Hormone Therapy.

11. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Rn7dRezgMx5syB-erQKoKt
    November 01, 2022 - Harms of hormone therapy No. of cases/total Treatment PlaceboOutcome Events per 10 000 persons (95% … for the treatment of meno- pausal symptoms. … Harms of hormone therapy No. of cases/total Treatment PlaceboOutcome Events per 10 000 persons (95% … The influence of hormone therapies on type I and II endometrial cancer: a nationwide cohort study. … Long-term effects of conjugated equine estrogen therapies on domain-specific cognitive function: results

12. Hormone Therapy for the Prevention of Chronic Conditions in Postmenopausal Women: Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/s9NcVWwGErrH9b9M_6NryW
    May 01, 2005 - hormone therapy for prevention of chronic disease (eg, age differences). … Hormone Replacement Therapy and Risk of Venous Thromboembolism. … Hormone Replacement Therapy and Cognition. … ACOG Task Force on Hormone Therapy. Hormone Therapy. … Menopausal hormone replacement therapy and risk of ovarian cancer.

13. Archived: Final Research Plan: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/menopausal-hormone-therapy-preventive-medication-december-2017
    October 22, 2015 - What is the average treatment duration of hormone therapy in women who initiate its use for the treatment … Administration–approved medications that are available for use in the United State Localized (nonsystemic) treatments … , such as rings or gels, contraceptives, and other hormones or treatments of menopausal symptoms (such … for the treatment of menopausal symptoms in the populations studied. … studies of women who are receiving hormone therapy for the treatment of menopausal symptoms will be included

14. Archived: Menopausal Hormone Therapy: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication-2012
    October 15, 2012 - limited to the treatment of menopausal symptoms and the prevention of osteoporosis. … Since the date given on the front of this form, has a doctor prescribed any of the following pills or treatments … specific form, dosage, and route of administration of the estrogen and progestin and estrogen-only therapies … Nonsurgical Treatments for Urinary Incontinence in Adult Women: Diagnosis and Comparative Effectiveness … Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin.

15. Evidence Summary: Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary28/menopausal-hormone-therapy-preventive-medication
    November 01, 2022 - for the treatment of menopausal symptoms. … The influence of hormone therapies on type I and II endometrial cancer: a nationwide cohort study. … Long-term effects of conjugated equine estrogen therapies on domain-specific cognitive function: results … Effects of combination estrogen plus progestin hormone treatment on cognition and affect. … Vascular effects of early versus late postmenopausal treatment with estradiol.

16. Archived: Comparative Effectiveness of Antiviral Treatment for Hepatitis C Virus Infection in Adults: A Systematic Review: Hepatitis C: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/comparative-effectiveness-of-antiviral-treatment-for-hepatitis-c-virus-infection-in-adults-a-systematic-review/hepatitis-c-screening-2013
    November 15, 2012 - For regimens longer than 12 weeks, dual therapy was continued to the end of treatment. … Harms of Antiviral Treatments Six head-to-head trials of dual therapy with pegylated interferon alfa … more effective treatments. … in part on the effectiveness of available treatments 81 . … hepatocellular carcinoma, liver transplantation rates, and quality of life) and harms of antiviral therapies

17. Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions: USPSTF Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/sTjqbTas6gW5pzaATpeBDn
    January 01, 2013 - limited to the treatment of menopausal symp- toms and the prevention of osteoporosis. … should be prescribed at the lowest effective dose and for the shortest duration of use consistent with treatment … specific form, dos- age, and route of administration of the estrogen and pro- gestin and estrogen-only therapies … Nonsurgical Treatments for Urinary Incontinence in Adult Women: Diagnosis and Comparative Effectiveness … Health risks and benefits 3 years after stopping ran- domized treatment with estrogen and progestin.

18. Archived: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication-december-2017
    December 12, 2017 - Treatment and Intervention Menopausal hormone therapy refers to the use of combined estrogen and progestin … The use of hormone therapy, whether administered orally, transdermally, or locally for the treatment … have reported on the risk of breast cancer as one of the primary adverse outcomes of treatment. … The Endocrine Society 40 also focuses primarily on the use of hormone therapy for the treatment of symptoms … Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline.

19. Postmenopausal Hormone Replacement Therapy for the Primary Prevention of Chronic Conditions: A Summary of the Evidence for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/sQ7hREGwnBm8Wh-LEFWP4F
    October 01, 2002 - Use of HRT for the treatment of symptoms of menopause and for the treatment of preexisting conditions … Hormone Postmenopausal Hormone Replacement Therapy 19 replacement treatment and breast cancer risk … Oral contraceptives, menopausal hormone replacement treatment and breast cancer risk. … Fracture protection provided by long-term estrogen treatment. … Treatment adherence and risk of death after a myocardial infarction.

20. Final Research Plan: Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/menopausal-hormone-therapy-preventive-medication
    May 27, 2021 - What is the average treatment duration in persons who start HT for menopausal symptoms? … Localized (nonsystemic) treatments such as rings, creams, or gels; contraceptives; other hormones; treatments … of menopausal symptoms such as over-the-counter preparations or compounded bioidentical therapies that … , progesterone only therapy, androgen therapy, and testosterone therapy; nonsystemic treatments are not … , androgen therapy, and testosterone therapy are not approved as HT in postmenopausal persons.